Merck & Co., Inc. (NYSE:MRK) is one of the 10 Best Value Stocks to Buy According to Billionaires. The company announced that the US FDA approved ENFLONSIA™ (clesrovimab-cfor) for the prevention of ...
Earlier this week, Merck MRK announced a definitive agreement to acquire Verona Pharma VRNA for approximately $10 billion. The deal will add Verona’s Ohtuvayre, approved for the maintenance treatment ...
Merck (NYSE:MRK) has received approval from the European Commission for its drug Winrevair (sotatercept), to be used in combination with other pulmonary arterial hypertension (PAH) therapies.
Merck pharmaceutical operations, vaccines, oncology medicines, and global research presence within the s&p 500 healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results